AR103484A1 - Triptólido y sus derivados en el tratamiento de tumores y patologías precancerosas de la piel - Google Patents

Triptólido y sus derivados en el tratamiento de tumores y patologías precancerosas de la piel

Info

Publication number
AR103484A1
AR103484A1 ARP160100173A ARP160100173A AR103484A1 AR 103484 A1 AR103484 A1 AR 103484A1 AR P160100173 A ARP160100173 A AR P160100173A AR P160100173 A ARP160100173 A AR P160100173A AR 103484 A1 AR103484 A1 AR 103484A1
Authority
AR
Argentina
Prior art keywords
derivatives
treatment
triptolid
precancer
tumors
Prior art date
Application number
ARP160100173A
Other languages
English (en)
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AR103484A1 publication Critical patent/AR103484A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuesto seleccionado de triptólido, sus derivados, y sales farmacéuticamente aceptables de triptólido y sus derivados, o una composición que comprende dicho un compuesto para su uso en el tratamiento tópico y/o prevención de un tumor o patología precancerosa de la piel.
ARP160100173A 2015-01-22 2016-01-22 Triptólido y sus derivados en el tratamiento de tumores y patologías precancerosas de la piel AR103484A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1550512A FR3031900A1 (fr) 2015-01-22 2015-01-22 Triptolide et ses derives dans le traitement des tumeurs et pathologies pre-cancereuses cutanees

Publications (1)

Publication Number Publication Date
AR103484A1 true AR103484A1 (es) 2017-05-10

Family

ID=53200086

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100173A AR103484A1 (es) 2015-01-22 2016-01-22 Triptólido y sus derivados en el tratamiento de tumores y patologías precancerosas de la piel

Country Status (4)

Country Link
AR (1) AR103484A1 (es)
FR (1) FR3031900A1 (es)
TW (1) TW201632182A (es)
WO (1) WO2016116587A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111440185B (zh) * 2020-03-31 2021-05-14 中国农业科学院蜜蜂研究所 一种半抗原及其在检测雷公藤乙素和雷公藤甲素方面的应用
CN111494319A (zh) * 2020-06-15 2020-08-07 沈阳药科大学 雷公藤甲素复方组合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728466A1 (fr) * 1994-12-26 1996-06-28 Debiopharm Sa Utilisation d'un extrait de tripterygium wilfordii hook f et de ses composants pour le traitement du melanome cancereux
US6629835B2 (en) * 2000-08-01 2003-10-07 Metaproteomics, Llc Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2
US8501214B2 (en) * 2007-11-26 2013-08-06 Modetex Biomedical Materials & Technology Industrial Corp. Hydrophilic foam and pharmaceutical dosage form employing the same
FR2952072B1 (fr) * 2009-11-05 2013-09-27 Pf Medicament Procede de production de triptolide

Also Published As

Publication number Publication date
WO2016116587A1 (en) 2016-07-28
FR3031900A1 (fr) 2016-07-29
TW201632182A (zh) 2016-09-16

Similar Documents

Publication Publication Date Title
CO2019007839A2 (es) Composiciones y métodos para inhibir la acción de la arginasa
CL2018003207A1 (es) Procedimientos para tratar cancer de piel a traves de la administración de un inhibidor pd-1.
CO2018008761A2 (es) Derivados de maitansinoide, conjugados de los mismos métodos de uso
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
CL2018001134A1 (es) Composiciones y métodos para inhibir la actividad arginasa
CO2017004525A2 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
CL2016001231A1 (es) Compuestos de inhibidor de autotaxina
CL2018003444A1 (es) Derivados de adenosina para uso en el tratamiento del cancer.
CL2016003422A1 (es) Inhibidores de demetilasa-1 específico de lisina
CL2012003415A1 (es) Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer .
CL2014001793A1 (es) Compuestos derivados de 1,3,5-triazinas sustituidas y sus sales, como inhibidores de la idh2 mutante; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer.
CL2016003423A1 (es) Inhibidores de demetilasa-1 específico de lisina
UY36153A (es) ?inhibidores de la fosfoinosítido 3-quinasa delta para su uso en el tratamiento de una enfermedad cutánea inmunoampollosa mediada por autoanticuerpos?
CL2016001756A1 (es) Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular.
BR112017011316A2 (pt) derivados heterocíclicos e uso destes
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
AR101414A1 (es) Derivados de pirrolidinona como inhibidores de metap-2
CL2016002151A1 (es) Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico
AR112144A1 (es) Compuestos para el tratamiento del sarcoma
NI201500175A (es) Compuestos nuevos para el tratamiento del cáncer
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
CU20150176A7 (es) Derivados de prodroga de triazolpiridinas sustituídas
AR100289A1 (es) Formas de un inhibidor de pi3k
AR103484A1 (es) Triptólido y sus derivados en el tratamiento de tumores y patologías precancerosas de la piel

Legal Events

Date Code Title Description
FB Suspension of granting procedure